Fundraising Fox
🦊/People
Sign in

Olga Danilchanka

Investor

Partner at MRL Ventures Fund · Board director at Therini Bio

Cambridge, Massachusetts

Writes $15M – $20M checks · typically $17.5M

Find your path to Olga

198 people in our graph share verified history with Olga — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedOlga: together at Evelo Biosciences (2015–2016)
×10Olga: together at Harvard Medical School
Olga: together at Ray Therapeutics, Inc.

About

Ph.D. and partner at MRL Ventures Fund.

Contact· self-published, not guessed

Board director at Therini Bio

Intro paths

→

In turn, Olga can intro founders to Therini Bio's investors below.

Therini Bio's investors · 9

Angelini VenturesRome · since 2025Apollo Health VenturesBerlin · since 2025Dementia Discovery FundLondon · since 2023Dolby Family VenturesSan Francisco · since 2023Levensohn Venture PartnersGeneva · since 2019Mitsui Global InvestmentMenlo Park · $500K – $10M checksMRL Ventures FundCambridge · $25M checks · since 2023Sanofi VenturesCambridge · $5M checks · since 2023SV Health InvestorsBoston · $1M – $20M checks · since 2019

Co-founders at Therini Bio

KAKaterina Akassoglou
Katerina AkassoglouScientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes
KAKaterina Akassoglou, PhD
Katerina Akassoglou, PhDScientific Founder

Experience

  1. MerckPartner, MRL Ventures Fundcurrent2024 — present
  2. MerckPrincipal, MRL Ventures Fund2021 — 2024
  3. MerckSenior Associate, MRL Ventures Fund2018 — 2021Cambridge, MA
  4. MerckPrincipal Scientist, Exploratory Science Center (ESC)2016 — 2018Cambridge, Massachusetts
  5. I&I newcoBoard Membercurrent2026 — present
  6. Ray Therapeutics, Inc.Board Observercurrent2024 — present
  7. Axonis TherapeuticsBoard Observercurrent2024 — present
  8. PAQ TherapeuticsBoard Directorcurrent2026 — present
  9. PAQ TherapeuticsBoard Observer2021 — 2026
  10. Ambagon TherapeuticsBoard Observercurrent2020 — present
  11. EyeBioBoard Observer2022 — 2024
  12. Caraway Therapeutics, Inc.Board Observer2021 — 2023
  13. Evelo BiosciencesSenior Scientist2015 — 2016Greater Boston Area
  14. Harvard Medical SchoolPostdoctoral Fellow2012 — 2015
  15. The University of Alabama at BirminghamPostdoctoral Fellow2010 — 2012

Skills & more

Analytical SkillsTeamworkProblem Solving1Oral Communication1SupervisionAccepting ResponsibilityMolecular Cloning24Microbiology27Molecular Biology25Venture CapitalInvestmentScientific Writing2
+12 moreTeachingTime ManagementPresentationsmicrobiomeDrug MetabolismIndependenceSelf-starterSelf-drivenMeet DeadlinesDelegate ManagementResult Orienteddesire to learn

Languages Belarusian · English · Russian

From Olga's professional profile.

Colleagues at MRL Ventures Fund

Dr. Amit N. Thakker
Africa Healthcare Adviser at Asia Africa Investment & Consulting (AAIC)
Jason Ruth
Partner at MRL Ventures Fund
Karin Kleinhans
Partner at MRL Ventures Fund
Melissa Danforth
General Counsel, Life Sciences at Bain Capital Life Sciences
Peter Dudek
President at MRL Ventures Fund
Priya Agrawal
MSD at i3 — Investing in Innovation Africa
Tao Fang
Senior Associate at MRL Ventures Fund

Frequently asked questions

Who is Olga Danilchanka?
Ph.D. and partner at MRL Ventures Fund.
Where does Olga Danilchanka work?
Olga Danilchanka is Partner at MRL Ventures Fund and Board director at Therini Bio.
What check size does Olga Danilchanka write?
Olga Danilchanka typically writes checks of $15M – $20M.
Where did Olga Danilchanka go to school?
Olga Danilchanka studied at University of Alabama at Birmingham (Doctor of Philosophy (Ph.D.)); Belarusian State University.

Same school

Shared employers